Protalix BioTherapeutics ... (PLX)
AMEX: PLX
· Real-Time Price · USD
1.38
-0.05 (-3.50%)
At close: Jun 17, 2025, 3:42 PM
1.36
-1.07%
After-hours: Jun 17, 2025, 04:00 PM EDT
Protalix BioTherapeutics Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|
| Product Revenue | 52.98M | 15.87M | 5.32M |
| Product Revenue Growth | +233.93% | +198.23% | n/a |
| License and Service Revenue | 418K | n/a | 25.26M |
| License and Service Revenue Growth | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|
| Brazil Revenue | 10.4M | 9.45M | 6.4M |
| Brazil Revenue Growth | +10.04% | +47.69% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.6M | 3M | 2.6M | 3.48M | 3.12M | 4.14M | 3.67M | 4.03M | 3.12M | 3.1M | 2.85M | 2.61M | 3.15M | 3.47M | 2.95M | 3.17M | 3.14M | 2.95M | 2.82M | 2.19M | 3.19M | 3.01M | 2.59M | 2.07M | 2.23M | 3.62M | 2.64M | 2.16M | 2.5M | 3.34M | 2.84M | 2.81M | 2.54M | 3.14M | 2.01M | 2.21M | 2M | 1.79M | 2.25M | 2.09M | 1.91M |
| Selling, General, and Administrative Revenue Growth | -13.20% | +15.57% | -25.52% | +11.85% | -24.81% | +12.89% | -8.96% | +29.41% | +0.55% | +8.78% | +9.08% | -17.22% | -9.00% | +17.33% | -6.84% | +1.05% | +6.34% | +4.79% | +28.35% | -31.16% | +5.74% | +16.51% | +25.10% | -7.26% | -38.43% | +37.30% | +22.24% | -13.61% | -25.28% | +17.88% | +0.78% | +10.92% | -19.23% | +55.96% | -8.70% | +10.58% | +11.33% | -20.50% | +7.74% | +9.36% | n/a |
| Research and Development Revenue | 3.48M | 4.12M | 3M | 2.96M | 2.89M | 3.1M | 3.67M | 4.47M | 5.85M | 5.62M | 7.39M | 7.58M | 8.77M | 7.64M | 7.28M | 7.69M | 7.12M | 10.95M | 7.69M | 9.19M | 10.34M | 9.6M | 10M | 13.32M | 11.7M | 9.97M | 10.07M | 7.24M | 6.44M | 8.99M | 6.39M | 8.83M | 4.63M | 5.71M | 5.06M | 7.82M | 6.03M | 7.7M | 5.26M | 6.47M | 6.76M |
| Research and Development Revenue Growth | -15.74% | +37.56% | +1.25% | +2.56% | -6.93% | -15.45% | -18.01% | -23.47% | +4.09% | -23.95% | -2.55% | -13.55% | +14.74% | +4.93% | -5.29% | +7.96% | -34.98% | +42.47% | -16.31% | -11.16% | +7.76% | -4.05% | -24.94% | +13.89% | +17.34% | -1.01% | +39.08% | +12.39% | -28.33% | +40.71% | -27.61% | +90.67% | -18.90% | +12.90% | -35.34% | +29.78% | -21.73% | +46.35% | -18.71% | -4.30% | n/a |